If the phosphorylation of key KCC2 sites does not occur as normal in HD gene carriers and patients, investigating how this affects the development hyperpolarising shift in EGABA is of concern; this research may provide an explanation for the behavioural and cognitive manifestations observed in HD patients. This evidence concerns the gene SLC12A5 and Huntington disease.